HSBC Holdings’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $160K | Buy |
25,185
+7,048
| +39% | +$44.9K | ﹤0.01% | 2278 |
|
|
2025
Q1 | $87.6K | Sell |
18,137
-590
| -3% | -$2.85K | ﹤0.01% | 2381 |
|
|
2024
Q4 | $178K | Sell |
18,727
-16,944
| -48% | -$161K | ﹤0.01% | 2334 |
|
|
2024
Q3 | $287K | Sell |
35,671
-52,008
| -59% | -$419K | ﹤0.01% | 2009 |
|
|
2024
Q2 | $614K | Buy |
87,679
+23,250
| +36% | +$163K | ﹤0.01% | 1548 |
|
|
2024
Q1 | $163K | Sell |
64,429
-72,228
| -53% | -$183K | ﹤0.01% | 2330 |
|
|
2023
Q4 | $326K | Buy |
136,657
+61,524
| +82% | +$147K | ﹤0.01% | 1794 |
|
|
2023
Q3 | $250K | Buy |
75,133
+56,129
| +295% | +$187K | ﹤0.01% | 1819 |
|
|
2023
Q2 | $140K | Sell |
19,004
-2,127
| -10% | -$15.7K | ﹤0.01% | 1959 |
|
|
2023
Q1 | $220K | Sell |
21,131
-6,715
| -24% | -$70K | ﹤0.01% | 1927 |
|
|
2022
Q4 | $321K | Buy |
+27,846
| New | +$321K | ﹤0.01% | 2048 |
|
|
2022
Q3 | – | Sell |
-16,053
| Closed | -$508K | – | 2532 |
|
|
2022
Q2 | $508K | Sell |
16,053
-4,116
| -20% | -$130K | ﹤0.01% | 1938 |
|
|
2022
Q1 | $841K | Buy |
20,169
+11,569
| +135% | +$482K | ﹤0.01% | 1746 |
|
|
2021
Q4 | $382K | Buy |
+8,600
| New | +$382K | ﹤0.01% | 2162 |
|
|
2021
Q1 | – | Sell |
-43,277
| Closed | -$3.88M | – | 2398 |
|
|
2020
Q4 | $3.88M | Sell |
43,277
-15,308
| -26% | -$1.37M | 0.01% | 874 |
|
|
2020
Q3 | $6.06M | Buy |
58,585
+50,210
| +600% | +$5.19M | 0.01% | 703 |
|
|
2020
Q2 | $662K | Buy |
8,375
+683
| +9% | +$54K | ﹤0.01% | 1327 |
|
|
2020
Q1 | $445K | Buy |
+7,692
| New | +$445K | ﹤0.01% | 1451 |
|
|
2019
Q2 | – | Sell |
-4,435
| Closed | -$223K | – | 2118 |
|
|
2019
Q1 | $223K | Buy |
+4,435
| New | +$223K | ﹤0.01% | 1969 |
|